Barriers to beating mood disorders
Health 24 - According to an executive of the National Depression and Manic Depression Association (NDMDA), Lydia Lewis, these new find it extremely difficult to stick to their treatment programmes and often decide to discontinue their medication
Source: www.health24.com
Akzo Nobel to proceed with partial listing of Organon pharma unit
Monsters and Critics - The listing of Organon received a setback in October last year when Akzo Nobel announced disappointing trial results for a new medication for schizophrenia and manic depression called asenapine. US pharmaceutical concern Pfizer said in November
Source: news.monstersandcritics.com
Click here for more information about manic depression manic depression
<< Home